Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,757,226
  • Shares Outstanding, K 122,181
  • Annual Sales, $ 9,437 M
  • Annual Income, $ 1,431 M
  • 60-Month Beta 1.04
  • Price/Sales 1.98
  • Price/Cash Flow 11.12
  • Price/Book 3.21
Trade DGX with:

Options Overview Details

View History
  • Implied Volatility 21.54%
  • Historical Volatility 12.49%
  • IV Percentile 26%
  • IV Rank 15.54%
  • IV High 41.31% on 10/30/20
  • IV Low 17.91% on 07/30/21
  • Put/Call Vol Ratio 0.20
  • Today's Volume 520
  • Volume Avg (30-Day) 1,073
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 10,928
  • Open Int (30-Day) 12,500

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 2.35
  • Number of Estimates 8
  • High Estimate 3.44
  • Low Estimate 2.03
  • Prior Year 4.31
  • Growth Rate Est. (year over year) -45.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
148.38 +3.17%
on 08/27/21
160.56 -4.65%
on 09/09/21
+3.56 (+2.38%)
since 08/24/21
3-Month
128.81 +18.85%
on 06/25/21
160.56 -4.65%
on 09/09/21
+23.90 (+18.50%)
since 06/24/21
52-Week
108.28 +41.38%
on 09/25/20
160.56 -4.65%
on 09/09/21
+43.90 (+40.21%)
since 09/24/20

Most Recent Stories

More News
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

VANCOUVER – USA News Group – More than 80 million workers in the United States are now facing ...

QGEN : 54.13 (-1.28%)
ABT : 124.37 (-0.74%)
QDEL : 146.94 (-4.25%)
DGX : 153.09 (-0.28%)
BIOV.CN : 0.495 (+1.02%)
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

DGX : 153.09 (-0.28%)
Bet on These 3 MedTech Growth Stocks for 2021 & Beyond

Stocks like West Pharmaceutical Services (WST), IDEXX Laboratories (IDXX) and Align Technology (ALGN) make great picks for the long term.

DGX : 153.09 (-0.28%)
ALGN : 725.24 (-0.26%)
IDXX : 679.64 (-0.43%)
WST : 457.11 (+0.42%)
3 Stocks to Buy if You're Worried About a Stock Market Crash

The market has been trending downward for the past three weeks and saw big declines today. This has made many investors uneasy. While David Cohne doesn't think a market crash will occur, he thinks investors...

CL : 76.63 (-0.05%)
DGX : 153.09 (-0.28%)
GWW : 405.35 (+0.49%)
Quest Diagnostics' (DGX) COVID-19 Test Demand Up in Q3 Months

The "Path Out of the Pandemic" plan of the U.S. Government, while emphasizing more on a magnified access for testing, comes as a major breakthrough for Quest Diagnostics (DGX).

DGX : 153.09 (-0.28%)
VREX : 27.82 (+1.72%)
NVST : 43.28 (+1.45%)
BRBR : 31.81 (-0.28%)
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate

Stocks like Quest Diagnostics (DGX), Quidel Corporation (QDEL) and LabCorp (LH) are the right picks now, thanks to rising COVID-19 testing demand.

ABT : 124.37 (-0.74%)
LH : 296.37 (-0.12%)
DGX : 153.09 (-0.28%)
QGEN : 54.13 (-1.28%)
QDEL : 146.94 (-4.25%)
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President's New OSHA Mandates

/PRNewswire/ --   -  More than 80 million workers in are now facing a being pushed by the Biden Administration through the Occupational Safety and Health Administration (OSHA) on employers with +100...

BIOV.CN : 0.495 (+1.02%)
BVAXF : 0.3954 (+4.27%)
QGEN : 54.13 (-1.28%)
ABT : 124.37 (-0.74%)
QDEL : 146.94 (-4.25%)
DGX : 153.09 (-0.28%)
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

VANCOUVER – USA News Group – More than 80 million workers in the United States are now facing ...

QGEN : 54.13 (-1.28%)
ABT : 124.37 (-0.74%)
QDEL : 146.94 (-4.25%)
DGX : 153.09 (-0.28%)
BIOV.CN : 0.495 (+1.02%)
Carnival Corporation to Provide Convenient Access to Pre-Board Testing

/PRNewswire/ -- (NYSE/LSE: CCL; NYSE: CUK), the world's largest cruise company, today announced a new initiative making pre-board testing more convenient and accessible for its guests. The effort will...

CCL : 25.44 (+3.04%)
CCL.LN : 1,683.200 (+2.35%)
CUK : 23.24 (+2.79%)
DGX : 153.09 (-0.28%)
Quest Diagnostic (DGX) Raises View on COVID-19 Testing Surge

Going by the current situation of daily increase in the coronavirus case count, Quest Diagnostics (DGX) expects COVID-19 molecular testing volumes to remain stronger through the rest of the year.

DGX : 153.09 (-0.28%)
VREX : 27.82 (+1.72%)
NVST : 43.28 (+1.45%)
BRBR : 31.81 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Key Turning Points

3rd Resistance Point 156.07
2nd Resistance Point 155.19
1st Resistance Point 154.14
Last Price 153.09
1st Support Level 152.21
2nd Support Level 151.32
3rd Support Level 150.27

See More

52-Week High 160.56
Last Price 153.09
Fibonacci 61.8% 140.59
Fibonacci 50% 134.42
Fibonacci 38.2% 128.25
52-Week Low 108.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar